Double cord blood transplant: a new hope for adults with blood cancer?

NCT ID NCT06712108

Recruiting now Disease control Sponsor: Seoul National University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is observing how well a double umbilical cord blood transplant works for 40 adults with blood cancers like leukemia or lymphoma. The transplant uses two units of cord blood from unrelated donors to help rebuild the patient's blood system. Researchers are tracking survival, engraftment, and side effects like graft-versus-host disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: double unit umbilical cord blood transplant
What this could lead to: If successful, this could show that a double cord blood transplant is a safe and effective option for adults with blood cancers who lack a matched donor.
What could go wrong: This is a small, observational study (40 people) that only looks at what happens in practice, not a controlled test. Risks include graft failure, infection, and graft-versus-host disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute leukemia aplastic anemia chronic leukemia lymphosarcoma myelodysplastic syndrome myeloproliferative neoplasm plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADULT DOUBLE UNIT CORD BLOOD TRANSPLANT

Contacts and locations

Locations

Dong-A University Hospital
NOT_YET_RECRUITING

Pusan, South Korea
Jeonbuk National University Hopital
NOT_YET_RECRUITING

Jeonju, Jeonlabuk-do, South Korea
Keimyung Unversity Dongsan Hospital
NOT_YET_RECRUITING

Daegu, South Korea
Pusan National University Hospital
NOT_YET_RECRUITING

Pusan, South Korea
Seoul National University Bundang Hospital
NOT_YET_RECRUITING

Seongnam, South Korea
Seoul National University Hospital
RECRUITING

Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.